Inhibition of Endothelial Cell Growth by Macrophage-like U-937 Cell-derived Oncostatin M, Leukemia Inhibitory Factor, and Transforming Growth Factor β1
Open Access
- 1 October 1996
- journal article
- Published by Elsevier
- Vol. 271 (40), 24901-24906
- https://doi.org/10.1074/jbc.271.40.24901
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Oncostatin M as a Potent Mitogen for AIDS-Kaposi's Sarcoma-Derived CellsScience, 1992
- Identification of an Inhibitor of Neovascularization from CartilageScience, 1990
- Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cellsBiochemical and Biophysical Research Communications, 1987
- Angiogenic FactorsScience, 1987
- Inhibition of endothelial cell proliferation by type β-transforming growth factor: Interactions with acidic and basic fibroblast growth factorsBiochemical and Biophysical Research Communications, 1986
- Anchorage‐independent growth of primary rat embryo cells is induced by platelet‐derived growth factor and inhibited by type‐beta transforming growth factorJournal of Cellular Physiology, 1986
- Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factorBiochemical and Biophysical Research Communications, 1985
- Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth FactorScience, 1984
- Hypothesis: Vasa Vasorum and Neovascularization of Human Coronary ArteriesNew England Journal of Medicine, 1984